Myocardial Infarction-Associated SNP at 6p24 Interferes with MEF2 Binding and Associates with PHACTR1 Expression Levels in Human Coronary Arteries

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 6, 2015, Pages 1472-1479

  Beaudoin, Mélissa ^a   Gupta, Rajat M ^c,d,e   Won, Hong Hee ^f,g,h,i   Lo, Ken Sin ^a   Do, Ron ^g,h,i   Henderson, Christopher A ^c   Lavoie St Amour, Claire ^a   Langlois, Simon ^a   Rivas, Daniel ^j   Lehoux, Stephanie ^j   Kathiresan, Sekar ^g,h,i   Tardif, Jean Claude ^b,k   Musunuru, Kiran ^c,d,e   Lettre, Guillaume ^a,b,k  

^a MONTREAL HEART INSTITUTE   (Canada)

^b Harvard University   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Center of Human Genetic Research   (United States)

^f Cardiovascular Research Center   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^j MCGILL UNIVERSITY   (Canada)

^k UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

coronary artery disease; genetic association studies; myocardial infarction

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ACTIN BINDING PROTEIN; PHACTR-1 PROTEIN, HUMAN;

ALLELE; ARTICLE; BINDING SITE; CANADIAN; CHROMOSOME 6P; CORONARY ARTERY; CORONARY ARTERY DISEASE; DNA SEQUENCE; ENDOTHELIUM CELL; GENE; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART INFARCTION; HETEROZYGOSITY; HUMAN; HUMAN CELL; IN VIVO STUDY; PHACTR1 GENE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SHEAR STRESS; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME 6; CORONARY BLOOD VESSEL; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; UMBILICUS; VASCULAR ENDOTHELIUM; VASCULARIZATION; VEIN;

ALLELES; CHROMOSOMES, HUMAN, PAIR 6; CORONARY VESSELS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MEF2 TRANSCRIPTION FACTORS; MICROFILAMENT PROTEINS; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; UMBILICUS; VEINS;

EID: 84933073514     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305534     Document Type: Article

References (42)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757. doi: 10.1016/S0140-6736(06)68770-9.
2. Barter PJ, Caulfield M, Eriksson M, et al; ILLUMINATE Investigators. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007;357:2109-2122. doi: 10.1056/NEJMoa0706628.
3. Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Lasala GP, Tuzcu EM; ILLUSTRATE Investigators. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 2007;356:1304-1316. doi: 10.1056/NEJMoa070635.
4. Schwartz GG, Olsson AG, Abt M, et al; dal-OUTCOMES Investigators. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012;367:2089-2099. doi: 10.1056/NEJMoa1206797.
5. Deloukas P, Kanoni S, Willenborg C, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nature genetics. 2013;45:25-33.
6. Kathiresan S, Voight BF, Purcell S, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature genetics. 2009;41:334-341. doi: 10.1038/ng.291.
7. Schunkert H, König IR, Kathiresan S, et al; Cardiogenics; CARDIoGRAM Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333-338. doi: 10.1038/ng.784.
8. Peden JF, Hopewell JC, Saleheen D, Chambers JC, Hager J, Soranzo N. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nature genetics. 2011;43:339-344.
9. Lu X, Wang L, Chen S, et al; Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Consortium. Genomewide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet. 2012;44:890-894. doi: 10.1038/ng.2337.
10. O'Donnell CJ, Kavousi M, Smith AV, et al; CARDIoGRAM Consortium. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation. 2011;124:2855-2864. doi: 10.1161/CIRCULATIONAHA.110.974899.
11. Hager J, Kamatani Y, Cazier JB, et al; FGENTCARD Consortium. Genome-wide association study in a Lebanese cohort confirms PHACTR1 as a major determinant of coronary artery stenosis. PLoS One. 2012;7:e38663. doi: 10.1371/journal.pone.0038663.
12. Freilinger T, Anttila V, de Vries B, et al; International Headache Genetics Consortium. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet. 2012;44:777-782. doi: 10.1038/ng.2307.
13. Patel RS, Morris AA, Ahmed Y, Kavtaradze N, Sher S, Su S, Zafari AM, Din-Dzietham R, Waddy SP, Vaccarino V, Alexander RW, Gibbons G, Quyyumi AA. A genetic risk variant for myocardial infarction on chromosome 6p24 is associated with impaired central hemodynamic indexes. Am J Hypertens. 2012;25:797-803. doi: 10.1038/ajh.2012.41.
14. Debette S, Kamatani Y, Metso TM, et al; International Stroke Genetics Consortium; CADISP group; CADISP group. Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection. Nat Genet. 2015;47:78-83. doi: 10.1038/ng.3154.
15. Allen PB, Greenfield AT, Svenningsson P, Haspeslagh DC, Greengard P. Phactrs 1-4: a family of protein phosphatase 1 and actin regulatory proteins. Proc Natl Acad Sci USA. 2004;101:7187-7192. doi: 10.1073/pnas.0401673101.
16. Allain B, Jarray R, Borriello L, Leforban B, Dufour S, Liu WQ, Pamonsinlapatham P, Bianco S, Larghero J, Hadj-Slimane R, Garbay C, Raynaud F, Lepelletier Y. Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cells. Cell Signal. 2012;24:214-223. doi: 10.1016/j.cellsig.2011.09.003.
17. Jarray R, Allain B, Borriello L, Biard D, Loukaci A, Larghero J, Hadj-Slimane R, Garbay C, Lepelletier Y, Raynaud F. Depletion of the novel protein PHACTR-1 from human endothelial cells abolishes tube formation and induces cell death receptor apoptosis. Biochimie. 2011;93:1668-1675. doi: 10.1016/j.biochi.2011.07.010.
18. Wiezlak M, Diring J, Abella J, Mouilleron S, Way M, McDonald NQ, Treisman R. G-actin regulates the shuttling and PP1 binding of the RPEL protein Phactr1 to control actomyosin assembly. J Cell Sci. 2012;125(pt 23):5860-5872. doi: 10.1242/jcs.112078.
19. Fils-Aime N, Dai M, Guo J, El-Mousawi M, Kahramangil B, Neel JC, Lebrun JJ. Microrna-584 and the protein phosphatase and actin regulator 1 (phactr1), a new signaling route through which transforming growth factor-beta mediates the migration and actin dynamics of breast cancer cells. J Biol Chem. 2013;288:11807-11823. doi: 10.1074/jbc.M112.430934.
20. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-1073. doi: 10.1038/nature09534.
21. 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65.
22. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34:816-834. doi: 10.1002/gepi.20533.
23. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336-2337. doi: 10.1093/bioinformatics/btq419.
24. Thomas J, Thomas DJ, Pearson T, Klag M, Mead L. Cardiovascular disease in African American and white physicians: the Meharry Cohort and Meharry-Hopkins Cohort Studies. J Health Care Poor Underserved. 1997;8:270-283; discussion 284.
25. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713. doi: 10.1038/nature09270.
26. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103-109. doi: 10.1038/nature10405.
27. Morris AP, Voight BF, Teslovich TM, et al; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981-990. doi: 10.1038/ng.2383.
28. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 2009;324:387-389. doi: 10.1126/science.1167728.
29. Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, Lettre G. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet. 2010;42:1049-1051. doi: 10.1038/ng.707.
30. Beaudoin M, Lo KS, N'Diaye A, Rivas MA, Dubé MP, Laplante N, Phillips MS, Rioux JD, Tardif JC, Lettre G. Pooled DNA resequencing of 68 myocardial infarction candidate genes in French Canadians. Circ Cardiovasc Genet. 2012;5:547-554. doi: 10.1161/CIRCGENETICS.112.963165.
31. Do R, Stitziel NO, Won HH, et al; NHLBI Exome Sequencing Project. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature. 2015;518:102-106. doi: 10.1038/nature13917.
32. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466:714-719. doi: 10.1038/nature09266.
33. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(database issue):D930-D934. doi: 10.1093/nar/gkr917.
34. Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development. 2007;134:4131-4140. doi: 10.1242/dev.008367.
35. Wang L, Fan C, Topol SE, Topol EJ, Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science. 2003;302:1578-1581. doi: 10.1126/science.1088477.
36. Liu Y, Niu W, Wu Z, Su X, Chen Q, Lu L, Jin W. Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis. PLoS One. 2012;7:e31406. doi: 10.1371/journal.pone.0031406.
37. Weng L, Kavaslar N, Ustaszewska A, Doelle H, Schackwitz W, Hébert S, Cohen JC, McPherson R, Pennacchio LA. Lack of MEF2A mutations in coronary artery disease. J Clin Invest. 2005;115:1016-1020. doi: 10.1172/JCI24186.
38. White MP, Rufaihah AJ, Liu L, Ghebremariam YT, Ivey KN, Cooke JP, Srivastava D. Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells. Stem Cells. 2013;31:92-103. doi: 10.1002/stem.1267.
39. Rufaihah AJ, Huang NF, Jamé S, Lee JC, Nguyen HN, Byers B, De A, Okogbaa J, Rollins M, Reijo-Pera R, Gambhir SS, Cooke JP. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2011;31:e72-e79. doi: 10.1161/ATVBAHA.111.230938.
40. Zhang X, Johnson AD, Hendricks AE, Hwang SJ, Tanriverdi K, Ganesh SK, Smith NL, Peyser PA, Freedman JE, O'Donnell CJ. Genetic associations with expression for genes implicated in GWAS studies for atherosclerotic cardiovascular disease and blood phenotypes. Hum Mol Genet. 2014;23:782-795. doi: 10.1093/hmg/ddt461.
41. Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol. 2009;8:668-678. doi: 10.1016/S1474-4422(09)70084-5.
42. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008;359:2767-2777. doi: 10.1056/NEJMoa0807917.